Literature DB >> 273570

Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia.

E L Prigogina, E W Fleischman, M A Volkova, M A Frenkel.   

Abstract

Forty cases of chronic myeloid leukemia (CML) were studied and subgroups of cases with similar chromosomal abnormalities in terminal stage were defined. Certain correlations were observed between the type of chromosomal changes, and clinical and morphologic manifestations of the disease: (1) It seems that, in cases without any karyotype changes other than translocation (9;22), the terminal stage is longer and milder than in cases with additional chromosomal abnormalities; (2) cases with marker i(17q) are clinically and morphologically rather uniform and are characterized by distinct signs of myeloid differentiation of blast cells, absent in other cases; (3) in cases with various atypical chromosomal abnormalities, the course of the terminal stage is the most rapid and grave. The blast cells differ from myeloblasts and resemble lymphoid elements.

Entities:  

Mesh:

Year:  1978        PMID: 273570     DOI: 10.1007/bf00273096

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

1.  Philadelphia chromosome in acute leukemia: case report.

Authors:  L M Walker; J D Hardy
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

2.  Chromosome banding studies in Philadelphia chromosome positive myeloid leukaemia.

Authors:  S D Lawler; F O'Malley; D S Lobb
Journal:  Scand J Haematol       Date:  1976-07

3.  G banding in cytogenetic study of hemoblastoses.

Authors:  E W Fleischman; E L Prigogina
Journal:  Humangenetik       Date:  1975

Review 4.  Editorial: Do human tumors show a chromosome pattern specific for each etiologic agent?

Authors:  J D Rowley
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

5.  Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Authors:  J D Rowley
Journal:  Nature       Date:  1973-06-01       Impact factor: 49.962

6.  A rapid banding technique for human chromosomes.

Authors:  M Seabright
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

7.  Identification of chromosome anomalies in the blastic phase of chronic myelocytic leukemia (CML) by Giemsa- and quinacrine-banding techniques.

Authors:  D K Hossfeld
Journal:  Humangenetik       Date:  1974-07-15

8.  Ph1-positive acute lymphocytic leukemia with chromosome 7 abnormalities.

Authors:  E M Mandel; F Shabtai; U Gafter; B Klein; I Halbrecht; M Djaldetti
Journal:  Blood       Date:  1977-02       Impact factor: 22.113

9.  Chromosomes and causation of human cancer and leukemia. XVI. Banding studies of chronic myelocytic leukemia, including five unusual Ph11 translocations.

Authors:  I Hayata; M Sakurai; S Kakati; A A Sandberg
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

10.  Certain patterns of karyotype evolution in chronic myelogeneous leukaemia. Chromosome abnormalities in CML.

Authors:  E L Prigogina; E W Fleischman
Journal:  Humangenetik       Date:  1975-11-06
View more
  9 in total

1.  Chromosomes in acute leukemia.

Authors:  E L Prigogina; E W Fleischman; G P Puchkova; O E Kulagina; S A Majakova; S A Balakirev; M A Frenkel; N V Khvatova; I S Peterson
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Inactive normal X in a female leukaemic patient with an acquired X/autosome translocation.

Authors:  B Dallapiccola; G Alimena
Journal:  Hum Genet       Date:  1979-04-27       Impact factor: 4.132

3.  Complete or partial trisomy for the long arm of chromosome 1 in patients with various hematologic malignancies.

Authors:  S E Mamaeva; N N Mamaev; N M Jartseva; L V Belyaeva; E G Scherbakova
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

4.  Chromosome abnormalities in chronic myeloid leukemia in children.

Authors:  G P Puchkova; E L Prigogina; E W Fleischmann; T S Drosdova; S A Mayakova; I S Peterson
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

5.  Megakaryoblastic micromegakaryocytic crisis in chronic myeloid leukemia.

Authors:  G Lingg; F Schmalzl; J Breton-Gorius; A Tabilio; H E Schaefer; D Geissler; M Schweiger; W Kirchmair
Journal:  Blut       Date:  1985-10

6.  Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML).

Authors:  O A Haas; J D Schwarzmeier; E Nacheva; P Fischer; E Paietta
Journal:  Blut       Date:  1984-01

7.  Translocations (4p+; 6q-) and (12q-; Xp+) in blastic phase of a Ph1-positive chronic myeloid leukemia.

Authors:  S Suciu; E Marinca; F Bornuz; M Crisan; L Petrov; E Rădulescu
Journal:  Blut       Date:  1984-10

8.  Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia.

Authors:  E W Fleischman; E L Prigogina; M A Volkova; M A Frenkel; N A Zakhartchenko; L N Konstantinova; G P Puchkova; S A Balakirev
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

9.  Prognostic significance of isochromosome 17q in hematologic malignancies.

Authors:  Dorota Koczkodaj; Justyna Muzyka-Kasietczuk; Sylwia Chocholska; Monika Podhorecka
Journal:  Oncotarget       Date:  2021-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.